How to continue Topamax after moving to Pennsylvania

If you’re struggling with Binge Eating Disorder (BED), you’ve likely wondered whether telehealth could offer a convenient path to treatment—especially when it comes to prescription medication. The short answer is yes, and the regulatory landscape in 2025-2026 has made it easier than ever. But understanding how it works, what medications are available, and what legal requirements apply can feel overwhelming.

This comprehensive guide breaks down everything you need to know about accessing BED medication through telehealth, including current federal and state regulations, medication options, safety considerations, and what to expect from your virtual care experience.

Understanding Telehealth for Mental Health and BED Treatment

Telehealth has transformed mental healthcare access, particularly for conditions like Binge Eating Disorder that benefit from specialized expertise. The COVID-19 pandemic accelerated regulatory changes that have largely become permanent, creating a robust framework for remote psychiatric and behavioral health care.

Binge Eating Disorder affects millions of Americans, characterized by recurrent episodes of eating large quantities of food in a short period, feeling out of control during these episodes, and experiencing significant distress—all without the compensatory purging behaviors seen in bulimia. According to DSM-5 criteria, BED requires these episodes to occur at least once weekly for three months.

Why Telehealth Works Well for BED Treatment

Several factors make telehealth particularly effective for BED care:

Accessibility: Many individuals with eating disorders face barriers to in-person treatment, including shame, transportation challenges, or limited local specialist availability. Telehealth removes these obstacles.

Continuity of care: Regular virtual check-ins are easier to maintain than in-person appointments, supporting the consistent monitoring that medication management requires.

Privacy and comfort: Discussing eating behaviors from home can feel less intimidating than sitting in a waiting room, potentially increasing treatment engagement.

Multidisciplinary coordination: Telehealth platforms often integrate medication management with therapy, nutrition counseling, and support resources in one accessible place.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Legal Landscape: Federal Telehealth Prescribing Rules in 2025-2026

Understanding the regulatory framework helps you know your rights and what to expect from legitimate telehealth providers.

Non-Controlled Medications: Fully Accessible via Telehealth

Here’s the critical distinction: Medications like Topamax (topiramate) and Wellbutrin (bupropion)—the primary off-label medications used for BED—are NOT controlled substances. This means they were never subject to the strict federal in-person requirements under the Ryan Haight Act, which only governs controlled substances (like stimulants, opioids, and benzodiazepines).

For these non-controlled BED medications, no federal law requires an in-person visit before prescribing via telehealth. Providers licensed in your state can conduct a thorough telehealth evaluation and prescribe these medications entirely online, as long as they meet the standard of care.

The DEA Extension Through 2026

While non-controlled medications remain unaffected, it’s worth understanding the broader context. The DEA has extended COVID-era telehealth flexibilities for controlled substances through December 31, 2026. This extension primarily impacts conditions requiring stimulants or other controlled medications.

For BED specifically, this matters because the only FDA-approved medication for BED—Vyvanse (lisdexamfetamine)—is a Schedule II controlled stimulant. Most telehealth providers do not prescribe controlled stimulants for BED due to regulatory complexity and abuse potential, instead focusing on the effective off-label non-controlled options we’ll discuss.

What This Means for You

Bottom line: If you’re seeking treatment for Binge Eating Disorder via telehealth in 2025-2026, you can access prescription medications like Topamax or Wellbutrin entirely online in every state, with no mandatory in-person visit required at the federal level. State-specific requirements may apply, which we’ll cover next.

State-by-State Telehealth Requirements: What You Need to Know

While federal law provides the foundation, each state sets additional requirements for telehealth prescribing. Here’s what matters most for BED medication access:

Most States: No In-Person Requirement for Non-Controlled Medications

The majority of states now explicitly allow telehealth evaluations to serve as the ‘prior examination’ needed before prescribing. States like California, New York, Texas, Florida, and Michigan have no in-person visit requirement for non-controlled medications like those used for BED.

California, for example, even allows asynchronous telehealth (online questionnaires plus review) to constitute an appropriate evaluation if it meets clinical standards—significantly expanding access.

States with Periodic In-Person Requirements

A few states require an in-person visit within a specific timeframe for ongoing telehealth treatment:

Alabama: After four telehealth visits within 12 months for the same condition, an in-person exam must occur within one year. This can be satisfied by any collaborating provider, not necessarily your telehealth prescriber.

Georgia: Requires attempting an annual in-person exam for continued telemedicine care, though initial evaluation can be done via telehealth if equivalent to in-person standards.

New Hampshire: For certain medications (primarily controlled substances), requires an in-person follow-up at least every 12 months, though this may not strictly apply to non-controlled BED medications.

These requirements are designed to ensure continuity and comprehensive care, not to block telehealth access. In practice, if you’re receiving BED treatment via telehealth in these states, your provider will coordinate any required in-person visits—often available through partner clinics or local providers.

Nurse Practitioners and Prescribing Authority

Who can prescribe your BED medication matters, especially since many telehealth platforms employ Nurse Practitioners (NPs) alongside physicians.

34 states plus DC now grant NPs Full Practice Authority, meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight. Recent additions include Wisconsin (2025), Michigan (2025), and Louisiana (2023).

In states like Texas, Florida, and Georgia, NPs must work under collaborative agreements with physicians. However, this doesn’t restrict their ability to prescribe non-controlled medications like Topamax or Wellbutrin—it’s simply a behind-the-scenes regulatory requirement that shouldn’t impact your care experience.

Klarity Health works with both physicians and nurse practitioners licensed in your state, ensuring you have access to qualified prescribers regardless of where you live. Our transparent approach means you’ll always know your provider’s credentials and how they’re authorized to care for you.

Medication Options for Binge Eating Disorder via Telehealth

While therapy remains the gold standard for BED treatment, medication can be an important component of a comprehensive treatment plan. Here’s what you need to know about the medications most commonly prescribed via telehealth for BED.

Topamax (Topiramate): How It Works for BED

What it is: Topiramate is an anticonvulsant originally FDA-approved for seizure disorders and migraine prevention. It’s used off-label for BED based on clinical research showing it can reduce binge frequency and support impulse control.

How it helps with BED: Topiramate appears to work by modulating neurotransmitters that affect appetite and reward pathways in the brain. Studies have shown it can reduce binge eating episodes and support weight management when combined with behavioral therapy.

Typical dosing: Treatment usually starts at a low dose (25mg) and gradually increases over several weeks to minimize side effects. Therapeutic doses for BED typically range from 75-200mg daily, though your provider will personalize this based on your response.

Important considerations:

• Pregnancy risk: Topiramate carries significant pregnancy warnings, including increased risk of cleft palate and other birth defects when taken during the first trimester. If you’re of childbearing potential, your provider will discuss effective contraception as part of treatment planning.

• Cognitive side effects: Some people experience ‘brain fog,’ word-finding difficulties, or slower thinking, especially at higher doses. Starting low and titrating slowly helps minimize this.

• Kidney stones: Staying well-hydrated is important, as topiramate can increase kidney stone risk.

• Discontinuation: Never stop topiramate suddenly—gradual tapering is essential to avoid seizure risk, even if you’ve never had seizures.

Telehealth prescribing: Because topiramate is not a controlled substance, it can be prescribed entirely via telehealth with no special restrictions. Your provider can issue prescriptions for up to 90 days with refills, though regular follow-up appointments are recommended to monitor effectiveness and side effects.

Wellbutrin (Bupropion): An Alternative Approach

What it is: Bupropion is an antidepressant FDA-approved for depression and smoking cessation. It’s used off-label for BED based on research suggesting it can reduce binge eating frequency in some patients.

How it helps with BED: Bupropion affects dopamine and norepinephrine pathways, which may help regulate appetite, reduce cravings, and improve mood—all relevant to BED treatment. Some patients find it particularly helpful when depression or low motivation accompanies their binge eating.

Typical dosing: Starting doses are typically 150mg once daily (often the sustained-release or extended-release formulation), potentially increasing to 300mg or 450mg daily based on response and tolerability.

Critical contraindications:

• Eating disorder history with purging: Bupropion is contraindicated in individuals with current or prior bulimia nervosa or anorexia nervosa due to significantly increased seizure risk. This is an FDA black-box warning. If you have a history of purging behaviors, your telehealth provider will not prescribe bupropion—it’s simply too dangerous.

• Seizure disorders: Any history of seizures makes bupropion inappropriate.

• Abrupt alcohol or benzodiazepine withdrawal: Can lower seizure threshold when combined with bupropion.

Black box warning: Like all antidepressants, bupropion carries a warning about increased suicidal thoughts in young adults (under 25). Your provider will monitor you closely, especially in the first weeks of treatment.

Additional considerations:

• Avoid alcohol entirely while taking bupropion, as it increases seizure risk
• Monitor blood pressure, as bupropion can cause mild elevations
• Common side effects include insomnia, dry mouth, and headache

Telehealth prescribing: Bupropion is freely prescribed via telehealth nationwide, with no in-person requirements. Providers can issue prescriptions for up to 90 days with refills for up to one year, though regular check-ins ensure safety and effectiveness.

Why Not Vyvanse via Telehealth?

Vyvanse (lisdexamfetamine) is the only FDA-approved medication specifically for moderate to severe BED in adults. However, as a Schedule II controlled stimulant, it faces stricter telehealth regulations.

Most legitimate telehealth platforms do not prescribe controlled stimulants for BED due to:

• Complex DEA regulations (even with current extensions)
• High potential for misuse and diversion
• Need for more intensive monitoring
• Regulatory scrutiny following enforcement actions against telehealth providers inappropriately prescribing stimulants

If your provider determines you might benefit from Vyvanse, they’ll typically refer you for an in-person evaluation with a specialist who can provide the comprehensive monitoring this medication requires.

The Telehealth Evaluation Process: What to Expect

Understanding what happens during a telehealth BED evaluation helps you prepare and ensures you get quality care.

Initial Assessment

A legitimate telehealth evaluation for BED medication should be comprehensive, typically lasting 30-60 minutes for the initial visit. Your provider will:

Review your eating patterns: Expect detailed questions about binge eating episodes—frequency, triggers, duration, quantities consumed, and feelings of loss of control. They’ll use DSM-5 criteria to determine if your symptoms meet BED diagnosis, which requires:

• Recurrent binge eating episodes (eating an unusually large amount in a discrete period with loss of control)
• At least once weekly for three months
• Significant distress about binge eating
• No regular compensatory behaviors like purging (which would suggest bulimia)

Medical history: Your provider will ask about:

• Other psychiatric conditions (depression, anxiety, ADHD)
• Previous eating disorder treatment
• Current medications and supplements
• Medical conditions (especially seizure disorders, kidney problems, pregnancy status)
• Substance use history
• Previous medication trials

Safety screening: Critical for medication selection:

• Current pregnancy status or plans
• History of bulimia or anorexia (eliminates bupropion as option)
• Seizure history
• Suicidal thoughts or self-harm
• Severity of medical complications from binge eating

Treatment goals: Discussion of what you hope to achieve—reducing binge frequency, addressing underlying mood issues, weight management, improving relationship with food.

Identity Verification and Licensing

Legitimate telehealth providers will:

• Verify your identity (via ID check or multi-factor authentication)
• Confirm your physical location to ensure the provider is licensed in your state
• Document this information for regulatory compliance

This isn’t invasion of privacy—it’s a legal requirement in many states ensuring you’re receiving care from an appropriately licensed professional.

Informed Consent

Before prescribing, your provider should discuss:

• Off-label use: Since Topamax and Wellbutrin aren’t FDA-approved specifically for BED, your provider will explain they’re being used ‘off-label’ based on clinical research and guidelines. This is completely legal and common—approximately 20% of all prescriptions are off-label uses.

• Risks and benefits: Detailed discussion of potential side effects, what to monitor, and expected benefits.

• Alternatives: Quality providers discuss other treatment options, including therapy (especially Cognitive Behavioral Therapy for BED), nutritional counseling, and support groups.

• Treatment plan: Clear explanation of dosing, titration schedule, follow-up appointments, and when to seek urgent help.

You’ll typically sign a telehealth consent form acknowledging you understand the limitations of virtual care and agreeing to the treatment approach.

Documentation and Treatment Plan

After evaluation, your provider should:

• Provide a clear diagnosis (BED) in your medical record
• Document the clinical rationale for medication choice
• Send prescriptions electronically to your chosen pharmacy
• Schedule follow-up appointments
• Provide contact information for questions or concerns between visits

Follow-Up Care and Monitoring

Starting BED medication via telehealth isn’t a one-and-done process—ongoing monitoring ensures safety and effectiveness.

Typical Follow-Up Schedule

First 2-4 weeks: Initial check-in to assess:

• How you’re tolerating the medication
• Any side effects
• Whether dosage adjustment is needed
• Early changes in binge eating frequency

Monthly for first 3-6 months: Regular visits to:

• Titrate dosage to optimal level
• Monitor for side effects
• Track progress in reducing binge episodes
• Assess need for additional support (therapy, nutrition)
• Coordinate with any other providers

Ongoing maintenance: Once stabilized, visits might space to every 2-3 months, though this varies by provider and state requirements.

What Providers Monitor

Clinical response:

• Reduction in binge eating frequency and severity
• Changes in eating patterns and food relationships
• Impact on weight (if relevant to your goals)
• Overall quality of life improvements

Safety parameters:

• Side effect emergence or worsening
• For topiramate: cognitive function, hydration status, pregnancy screening if applicable
• For bupropion: mood changes, suicidal ideation (especially first 8 weeks), blood pressure
• Medication interactions if you start other treatments

Adherence and barriers:

• Are you taking medication as prescribed?
• Cost or access issues with pharmacy?
• Questions or concerns about treatment?

Refills and Long-Term Management

Because these are non-controlled medications, providers can typically:

• Prescribe 90-day supplies
• Authorize up to 11 refills (one year of treatment)
• Allow pharmacy auto-refills if desired

However, most providers require regular visits even if refills are automatic. This isn’t about control—it’s about ensuring the medication continues to be appropriate and effective for you.

States like Alabama, Georgia, and New Hampshire may require periodic in-person visits (typically annual) for continued telehealth prescribing. Your provider will coordinate these if needed.

Safety Considerations and Red Flags

The telehealth boom has brought incredible access, but also some bad actors. Here’s how to ensure you’re getting quality care.

Signs of Legitimate Telehealth Care

Comprehensive evaluation: If a service offers to prescribe medication after a 5-minute questionnaire, that’s a red flag. Proper BED evaluation takes time.

Licensed providers: Verify your provider is licensed in your state. Legitimate platforms display provider credentials clearly and can provide license numbers upon request.

Proper documentation: You should receive visit summaries, treatment plans, and have access to your medical records.

Integration with other care: Quality providers encourage therapy, discuss non-medication approaches, and can coordinate with your other healthcare providers.

Realistic expectations: Beware of providers promising dramatic results or ‘guaranteed’ outcomes. BED is complex—medication helps but isn’t magic.

Standard pharmacy practices: Prescriptions should go to regular pharmacies (CVS, Walgreens, mail-order like Optum), not mysterious ‘affiliated pharmacies’ shipping from unknown locations.

Warning Signs of Questionable Providers

• Prescribing before a comprehensive evaluation
• Pressure to purchase medication from them directly
• Unwillingness to coordinate with your other healthcare providers
• No follow-up care offered or required
• Prescribing controlled substances too readily
• Lack of emergency protocols or after-hours support
• No state licensure verification available

Recent Enforcement Actions

The 2024 indictment of executives from a telehealth ADHD startup for allegedly running a ‘pill mill’ operation prescribing 40 million Adderall pills inappropriately serves as a cautionary tale. This enforcement action targeted controlled substance prescribing without proper evaluation.

For BED medications (non-controlled), the risk is different but still important: providers who prescribe without adequate assessment, fail to monitor for contraindications, or don’t provide ongoing care aren’t just violating best practices—they’re potentially endangering patients.

Klarity Health prioritizes safety through comprehensive evaluations, licensed providers practicing within their scope, regular follow-up care, and transparent pricing (accepting both insurance and cash pay). We believe access shouldn’t compromise quality.

Insurance Coverage and Cost Considerations

Understanding the financial aspects helps you plan for treatment.

Insurance Coverage for Telehealth BED Treatment

Parity laws: Mental health conditions, including eating disorders, must be covered at parity with physical health conditions under federal law. This includes telehealth services.

Telehealth coverage: Most major insurers now cover telehealth mental health visits at the same rate as in-person visits. Some states require this by law; the federal Public Health Emergency extensions made it standard practice.

Medication coverage: Coverage for Topamax and Wellbutrin varies by plan:

• Generic versions (topiramate, bupropion) are widely covered with low copays, often on Tier 1 or 2 formularies
• Brand names may require prior authorization or have higher copays
• Off-label uses might trigger prior authorization requirements where insurers verify medical necessity

Prior authorization: Some insurers require documentation that you meet criteria for BED and that first-line treatments have been tried or discussed. Your telehealth provider should be familiar with this process and can provide necessary documentation.

Cash-Pay Options

If you’re uninsured or prefer not to use insurance:

Telehealth visit costs: Initial evaluations typically range from $150-$300, with follow-ups $75-$150. Subscription models (monthly fees for unlimited visits) may offer better value for ongoing care.

Medication costs:

• Generic topiramate: $10-$30 per month without insurance
• Generic bupropion: $10-$40 per month without insurance
• Discount programs like GoodRx can significantly reduce costs

Klarity Health offers transparent pricing whether you’re using insurance or paying cash, with clear fee schedules upfront. We accept both payment types because we believe financial barriers shouldn’t prevent access to necessary mental healthcare.

Comparing Telehealth vs. In-Person Costs

Telehealth often proves more cost-effective when you factor in:

• No transportation costs
• No parking fees
• No time off work for travel
• Often lower copays than specialist in-person visits
• Access to providers who might not be locally available

Who Benefits Most from Telehealth BED Treatment?

Telehealth medication management works well for many people with BED, but it’s especially beneficial for:

Ideal Candidates

Geographic barriers: Living in rural areas or locations with limited eating disorder specialists makes telehealth invaluable.

Busy schedules: Healthcare professionals, parents, or shift workers who struggle to attend in-person appointments during business hours.

Mild to moderate severity: Those with BED who are medically stable and don’t require intensive in-person monitoring.

Motivated for treatment: People committed to regular appointments and honest communication with providers.

Technology access: Comfortable with video calls and have reliable internet access.

Privacy concerns: Those who feel more comfortable discussing eating behaviors from home.

When In-Person Care is Better

Telehealth may not be appropriate if you:

Have severe medical complications: Severe obesity with acute health risks, uncontrolled diabetes, cardiovascular instability, or other conditions requiring hands-on medical assessment.

Need intensive treatment: If you’re significantly malnourished, experiencing frequent medical crises from binge eating, or have attempted suicide, you may need intensive outpatient or even residential treatment.

Have active purging: Current bulimia nervosa or purging behaviors make bupropion dangerous and require specialized in-person care.

Require controlled medications: If evaluation suggests you’d benefit from Vyvanse or other controlled substances, in-person care is typically necessary.

Lack stable environment: Homelessness, unstable housing, or abusive situations may make telehealth ineffective or unsafe.

Need complex coordination: Multiple severe psychiatric conditions requiring frequent medication adjustments might benefit from in-person specialty care.

A quality telehealth provider will recognize when in-person care is more appropriate and make referrals accordingly.

Combining Medication with Therapy and Other Supports

Medication alone isn’t usually sufficient for BED—it works best as part of a comprehensive approach.

Cognitive Behavioral Therapy (CBT)

CBT specifically adapted for BED has the strongest research support of any treatment. It helps you:

• Identify triggers for binge eating
• Develop alternative coping strategies
• Challenge distorted thoughts about food, weight, and body image
• Establish regular eating patterns
• Build skills to prevent relapse

Many telehealth platforms offer both medication management and therapy—sometimes called ‘collaborative care.’ This integration often produces better outcomes than either approach alone.

Nutritional Counseling

Working with a registered dietitian who specializes in eating disorders can help you:

• Develop balanced, sustainable eating patterns
• Address nutritional deficiencies
• Learn intuitive eating principles
• Challenge diet culture messaging
• Create meal plans that work with your life

Support Groups

Peer support—whether through organizations like Overeaters Anonymous, NEDA support groups, or online communities—provides validation, reduces isolation, and offers practical strategies from others who understand.

Physical Activity

Gentle, joyful movement (not punitive exercise) can improve mood, reduce stress, and support overall health. A healthcare provider can help you develop a healthy relationship with movement.

Medication’s Role

In this context, medication serves as a tool that can:

• Reduce urges to binge while you develop coping skills
• Address underlying depression or anxiety fueling the disorder
• Create a window where therapy can be more effective
• Support initial behavior changes that become sustainable over time

Klarity Health’s approach recognizes that medication is one component of comprehensive BED care. Our providers can connect you with therapy resources, nutritional support, and other services that complement medication management.

The Future of Telehealth BED Treatment: What’s Ahead

Evolving Regulations

The DEA is expected to issue final rules on telehealth prescribing for controlled substances by end of 2026. While this won’t affect non-controlled BED medications directly, it will shape the overall telehealth landscape.

States continue to refine their telehealth laws, generally trending toward:

• Greater access and fewer barriers
• Interstate licensure compacts making it easier for providers to serve patients across state lines
• Enhanced patient protections and quality standards
• Expanded insurance coverage requirements

Technology Advances

Emerging technologies that may enhance BED telehealth care include:

• AI-assisted screening tools to identify BED earlier and more accurately
• Wearable devices tracking eating patterns, mood, and physiological stress
• Virtual reality exposures for anxiety and trigger management
• Asynchronous care platforms allowing more flexible communication between appointments

Research and Treatment Development

Ongoing research into BED treatments may bring:

• New medications with BED-specific FDA approval
• Better understanding of which medications work best for which patients
• Combination therapy protocols optimized for telehealth delivery
• Improved integration of medication management with digital therapeutics

Practical Steps: How to Get Started with Telehealth BED Treatment

Ready to explore telehealth medication for Binge Eating Disorder? Here’s your roadmap:

Step 1: Prepare for Your Evaluation

Gather information to share with your provider:

• Eating pattern journal: Track binge episodes for 1-2 weeks—what you ate, how much, triggers, feelings
• Medical history: List current medications, health conditions, previous treatments
• Treatment goals: Think about what you want to achieve
• Questions: Write down concerns or questions about medication

Step 2: Choose a Reputable Telehealth Provider

Look for:

• Licensed providers in your state
• Transparent credentials and qualifications
• Clear pricing and insurance policies
• Comprehensive evaluation process
• Good reviews and established reputation
• Follow-up care protocols

Step 3: Complete Initial Evaluation

Be prepared to:

• Spend 30-60 minutes in video consultation
• Discuss eating patterns in detail
• Review medical and psychiatric history
• Ask questions about treatment options
• Provide consent for treatment

Step 4: Start Treatment Carefully

If medication is prescribed:

• Fill prescription at your preferred pharmacy
• Follow titration schedule exactly as prescribed
• Keep a symptom journal tracking effects
• Report side effects promptly
• Attend all scheduled follow-ups
• Don’t change dosages without provider guidance

Step 5: Engage with Comprehensive Care

Maximize treatment effectiveness by:

• Starting or continuing therapy
• Joining support groups
• Working with a dietitian if possible
• Building healthy coping strategies
• Tracking progress honestly
• Communicating openly with your provider

Take the Next Step Toward Recovery

Binge Eating Disorder doesn’t have to control your life. Telehealth has made evidence-based treatment more accessible than ever, removing barriers that once stood between you and recovery.

The regulatory framework in 2025-2026 supports safe, legal access to BED medications like Topamax and Wellbutrin through telehealth platforms. You don’t need to wait for an in-person appointment months away or travel hours to see a specialist—quality care can come to you, on your schedule.

At Klarity Health, we make BED treatment accessible through:

• Licensed providers in your state offering comprehensive evaluations and ongoing care
• Transparent pricing with both insurance and cash-pay options
• Flexible scheduling that works with your life
• Integrated approach connecting medication management with therapy and support resources
• Commitment to quality that prioritizes your safety and treatment success

Recovery from Binge Eating Disorder is possible. Medication can be a valuable tool in your journey, helping reduce binge urges while you build sustainable coping strategies. With telehealth removing traditional barriers to care, there’s no better time to take that first step.

Ready to explore whether medication might help your BED recovery? Klarity Health’s providers are here to offer judgment-free evaluation, evidence-based treatment, and ongoing support tailored to your needs.

References

1. U.S. Department of Health and Human Services. (2026). DEA extends telemedicine prescribing flexibilities through December 31, 2026. HHS.gov. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Health Law. (2025). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. (2025). State telehealth laws and reimbursement policies: Online prescribing. CCHP Telehealth Policy Database. https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. (2025). State-by-state guide: Expanding roles for PAs and NPs (Updated 2025). https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. U.S. Food and Drug Administration. Wellbutrin (bupropion hydrochloride) prescribing information. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

📅 RESEARCH CURRENCY STATEMENT
Verified as of: January 4, 2026

Federal Status: DEA telehealth prescribing flexibilities for controlled substances remain in effect through December 31, 2026 (fourth extension). Non-controlled medications (including those discussed for BED) were never subject to Ryan Haight Act restrictions and remain freely prescribable via telehealth.

State Verification: Researched 10+ key states with information current as of late 2025. State medical and nursing board sites and 2025 legislative updates were checked where available.

Source Currency: 80%+ of sources are from 2025 (many late-2025) or updated to reflect 2025 status. Older sources used only when confirmed still accurate by newer references.

⚠️ Pending Monitoring: Alabama and South Carolina NP scope-of-practice legislation discussed in 2025 but final status pending confirmation. DEA’s final rule on permanent telehealth prescribing expected by end of 2026.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12